Skip to main content
logo
Maze Therapeutics, Inc. (MAZE)
NASDAQ: MAZE · Real-Time Price · USD
24.79
-0.04 (-0.14%)
At close: Sep 11, 2026, 4:00 PM EDT
24.60
-0.18 (-0.75%)
After-hours: Sep 11, 2026, 7:30 PM EDT

Maze Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Equivalents
202.64189.25196.8129.1699.92
Short-Term Investments
208.44152.67---
Cash & Short-Term Investments
411.09341.92196.8129.1699.92
Cash Growth
55.40%73.73%574.99%-70.82%-
Other Receivables
2.81.5---
Receivables
2.81.5---
Prepaid Expenses
6.546.34.864.956.23
Total Current Assets
420.42349.72201.6734.11106.15
Property, Plant & Equipment
22.8325.1629.9234.9841.23
Long-Term Investments
83.8218.11---
Long-Term Deferred Charges
--4.6--
Other Long-Term Assets
4.554.144.352.412.58
Total Assets
531.63397.13240.5471.5149.96

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Accounts Payable
2.211.791.942.021.59
Accrued Expenses
15.8715.9714.19.8114.87
Current Portion of Leases
4.884.84.634.494.32
Total Current Liabilities
22.9622.5620.6716.3220.78
Long-Term Debt
38.96--20.08-
Long-Term Leases
16.5818.512225.0527.73
Other Long-Term Liabilities
-1.090.97--
Total Liabilities
78.542.1643.6461.4548.51

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Common Stock
0.060.05000.02
Additional Paid-In Capital
1,012844.3547.2421.8412.79
Retained Earnings
-558.48-489.55-358.43-395.69-295.27
Comprehensive Income & Other
-0.440.11---
Total Common Equity
453.12354.97-311.18-373.85-282.46
Shareholders' Equity
453.12354.97196.910.05101.44
Total Liabilities & Equity
531.63397.13240.5471.5149.96

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Total Debt
60.4223.3126.6349.6232.06
Net Cash (Debt)
434.49318.61170.18-20.4767.86
Net Cash Growth
81.39%87.22%---
Net Cash Per Share
8.197.4162.33-8.9433.76
Filing Date Shares Outstanding
55.5549.7143.82.322.01
Total Common Shares Outstanding
55.549.332.442.322.01
Working Capital
397.46327.1618117.7985.37
Book Value Per Share
8.167.20-127.72-160.95-140.52
Tangible Book Value
453.12354.97-311.18-373.85-282.46
Tangible Book Value Per Share
8.167.20-127.72-160.95-140.52
Machinery
-17.9717.3116.4716.08
Construction In Progress
-0.040.030.06-
Leasehold Improvements
-5.515.455.365.33
SEC Filings: 10-K · 10-Q